By Gavin Duvall
In Arch Venture Partners, biology, biotechnology, BlueYard Capital, cambridge university, cancer, CRISPR, Director, Disease, drug development, drug discovery, Foresite Capital, founder, Grail, Juno, Life Sciences, Meatable, operating system, stem cells, TC, United Kingdom
Posted Bit Bio’s “enter button for the keyboard to the software of life” nabs the company $41.5 million
Bit Bio, the new startup which pitches itself as the “enter button for the keyboard to the software of life” only needed three weeks to raise its latest $41.5 million round of [...]